PURE : Summary for PURE BIOSCIENCE IN COM NPV - Yahoo Finance

U.S. Markets open in 7 hrs 4 mins

PURE Bioscience, Inc. (PURE)


Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.95+0.02 (+2.14%)
At close: 3:41 PM EST
People also watch:
HEBVICLQDELSVAAPT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close0.93
Open0.00
Bid0.00 x
Ask0.00 x
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. Volume53,952
Market Cap61.58M
Beta-1.99
PE Ratio (TTM)-3.75
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Business Wire8 days ago

    PURE Bioscience Sets Fiscal 2017 Q1 Results Conference Call

    PURE Bioscience, Inc. , creator of the patented silver dihydrogen citrate antimicrobial, announced today that on December 14, 2016 the Company will file its Form 10-Q shortly after the close of the market.

  • PURE Bioscience, Inc. :PURE-US: Earnings Analysis: 2016 By the Numbers : November 22, 2016
    Capital Cube16 days ago

    PURE Bioscience, Inc. :PURE-US: Earnings Analysis: 2016 By the Numbers : November 22, 2016

    Categories: Yahoo Finance Get free summary analysis PURE Bioscience, Inc. reports financial results for the year ended July 31, 2016. We analyze the earnings along side the following peers of PURE Bioscience, Inc. – Ecolab Inc., Ocean Bio-Chem, Inc., United-Guardian, Inc. and Calgon Carbon Corporation (ECL-US, OBCI-US, UG-US and CCC-US) that have also reported for this period. Highlights ... Read more (Read more...)

  • Accesswire17 days ago

    PURE Bioscience to Present at the 9th Annual LD Micro Conference

    SAN DIEGO, CA / ACCESSWIRE / November 21, 2016 / PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented silver dihydrogen citrate ( SDC ) antimicrobial, today announced that Hank R. Lambert, CEO ...